Li Yang, Nie Yunzhong, Yang Xia, Liu Yang, Deng Xiaoshan, Hayashi Yoshihito, Plummer Riana, Li Qinglin, Luo Na, Kasai Toshiharu, Okumura Takashi, Kamishibahara Yu, Komoto Takemasa, Ohkuma Takuya, Okamoto Satoshi, Isobe Yumiko, Yamaguchi Kiyoshi, Furukawa Yoichi, Taniguchi Hideki
Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Minato, Tokyo 108-8639, Japan; Division of Regenerative Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Minato, Tokyo 108-8639, Japan.
Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Minato, Tokyo 108-8639, Japan; Division of Regenerative Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Minato, Tokyo 108-8639, Japan; Advanced Medical Research Center, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Cell Rep. 2024 Mar 26;43(3):113918. doi: 10.1016/j.celrep.2024.113918. Epub 2024 Mar 6.
Maximizing the potential of human liver organoids (LOs) for modeling human septic liver requires the integration of innate immune cells, particularly resident macrophage Kupffer cells. In this study, we present a strategy to generate LOs containing Kupffer cells (KuLOs) by recapitulating fetal liver hematopoiesis using human induced pluripotent stem cell (hiPSC)-derived erythro-myeloid progenitors (EMPs), the origin of tissue-resident macrophages, and hiPSC-derived LOs. Remarkably, LOs actively promote EMP hematopoiesis toward myeloid and erythroid lineages. Moreover, supplementing with macrophage colony-stimulating factor (M-CSF) proves crucial in sustaining the hematopoietic population during the establishment of KuLOs. Exposing KuLOs to sepsis-like endotoxins leads to significant organoid dysfunction that closely resembles the pathological characteristics of the human septic liver. Furthermore, we observe a notable functional recovery in KuLOs upon endotoxin elimination, which is accelerated by using Toll-like receptor-4-directed endotoxin antagonist. Our study represents a comprehensive framework for integrating hematopoietic cells into organoids, facilitating in-depth investigations into inflammation-mediated liver pathologies.
要使人类肝脏类器官(LOs)在模拟人类脓毒症肝脏方面发挥最大潜力,需要整合先天免疫细胞,特别是驻留巨噬细胞库普弗细胞。在本研究中,我们提出了一种策略,通过使用人类诱导多能干细胞(hiPSC)衍生的红系 - 髓系祖细胞(EMPs)(组织驻留巨噬细胞的起源)和hiPSC衍生的LOs来重现胎儿肝脏造血过程,从而生成含有库普弗细胞的LOs(KuLOs)。值得注意的是,LOs能积极促进EMPs向髓系和红系谱系的造血。此外,事实证明,在建立KuLOs的过程中,补充巨噬细胞集落刺激因子(M - CSF)对于维持造血细胞群体至关重要。将KuLOs暴露于类败血症内毒素会导致明显的类器官功能障碍,这与人类脓毒症肝脏的病理特征极为相似。此外,我们观察到在内毒素消除后,KuLOs有显著的功能恢复,使用Toll样受体4导向的内毒素拮抗剂可加速这一恢复过程。我们的研究为将造血细胞整合到类器官中提供了一个全面的框架,有助于深入研究炎症介导的肝脏病理。